advertisement

Topcon

Tokumo K 12

Showing records 1 to 12 | Display all abstracts from Tokumo K

109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Nurtania A
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Mizuno Y; Komatsu K
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Kiuchi Y
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Tokumo K
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Muhlisah A; Hirooka K
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Okada N; Onoe H
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Okada N
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Okumichi H
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Onoe H
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Hirooka K
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Tokumo K
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Miura Y; Kiuchi Y
Contemporary clinical trials communications 2023; 33: 101160

Issue 24-1

Change Issue


advertisement

Oculus